Table 2.
S. No. | Target | Diseases or Pathogenic agent | References |
---|---|---|---|
DNA aptamer | |||
1. | AS1411 | Acute myeloid leukemia | Ireson and Kelland, 2006 |
2. | SARS-CoV N protein | Pathogenic agent | Cho et al., 2011 |
3. | E. coli K88 | Pathogenic agent | Hong and Sooter, 2015 |
4. | Salmonella Paratyphi A | Pathogenic agent | Hong and Sooter, 2015 |
5. | Listeria monocytogenes | Pathogenic agent | Hong and Sooter, 2015 |
6. | Shigella dysenteriae | Pathogenic agent | Hong and Sooter, 2015 |
7. | Streptococcus mutans | Pathogenic agent | Hong and Sooter, 2015 |
8. | Francisella tularensis subspecies(subsp.) japonica bacterial antigen | Pathogenic agent | Hong and Sooter, 2015 |
9. | HIV reverse transcriptase | Pathogenic agent | Hong and Sooter, 2015 |
10. | Dengue virus type-2 envelope protein domain III | Pathogenic agent | Hong and Sooter, 2015 |
11. | HCV envelope surface glycoprotein E2 |
Pathogenic agent | Hong and Sooter, 2015 |
12. | Avian influenza H5N1 | Pathogenic agent | Hong and Sooter, 2015 |
13. |
Mycobacterium
tuberculosis H37Rv |
Pathogenic agent | Hong and Sooter, 2015 |
14. | ARC1772 | Thrombosis | Nimjee et al., 2017 |
15. | PTK7 aptamer | Leukemia | Nimjee et al., 2017 |
16. | Nu172 | Anticoagulation | Maimaitiyiming et al., 2019 |
17. | E10030 | Age-related macular degeneration (AMD) |
Maimaitiyiming et al., 2019 |
18. | N55 | Atherosclerosis | Sola et al., 2020 |
19. | GBI-10 | In several types of tumors | Sola et al., 2020 |
20. | SQ-2 | Pancreatic ductal adenocarcinoma (PDAC) |
Sola et al., 2020 |
RNA aptamer | |||
21. | A9 and A10 | Prostate cancer | Nimjee et al., 2017 |
22. | RNA 14-16 against p68, helicase |
Liver metastasis | Nimjee et al., 2017 |
23. | Pegaptanib | AMD | Nimjee et al., 2017 |
24. | ARC1905 | AMD | Maimaitiyiming et al., 2019 |
25. | ARC19499 | Hemophilia | Maimaitiyiming et al., 2019 |
26. | NOX-H94 | Anemia | Maimaitiyiming et al., 2019 |
27. | EYE001 | AMD | Maimaitiyiming et al., 2019 |
28. | MRP1Apt | Melanoma cancer stem cells | Sola et al., 2020 |
29. | A1 | Breast cancer cells | Sola et al., 2020 |
30. | G-3 | HIV infection blockade | Sola et al., 2020 |
31. | P30-10-16 | Influenza B virus infection blockade |
Sola et al., 2020 |
32. | PB | Prostate cancer | Sola et al., 2020 |
33. | GL21.T | Axl-dependent cancers | Sola et al., 2020 |
SOMAmer: Slow-Off-rate-Modified-Aptamer | |||
34. |
Clostridium
difficile binary toxin (CdtA) |
Pathogenic agent | Ochsner et al., 2014 |
35. | Proprotein convertase subtilisin/kexin type 9 |
Disease | Gawande et al., 2017 |
36. | Vaccine antigen in the human papillomavirus (HPV) vaccine Gardasil |
Pathogenic agent | Trausch JJ et al., 2017 |
37. | Glypican-3 SOMAmer | Hepatocellular carcinoma (HCC) |
Duo et al., 2018 |
38. |
Mycobacterium
tuberculosis |
Pathogenic agent | Golichenari et al., 2018 |